Community Pharmacy England (CPE) - News updates

The Department of Health and Social Care (DHSC) has today (19/06/2026) confirmed the following initial list of price concessions for June 2026: Drug Pack size Price concession Aripiprazole 10mg tablets 28 £3.15 Aspirin 75mg dispersible tablets 28 £2.36 Aspirin 75mg dispersible tablets 100 £8.42 Aspirin 75mg gastro-resistant tablets 28 £2.02 Aspirin 75mg tablets 28 £1.63 Azathioprine [...] The post June 2026 Price Concessions 1st Update appeared first on Community Pharmacy England.

NHS England has authorised and the UK Health Security Agency (UKHSA) has published the Patient Group Direction (PGD) and Vaccine Group Direction (VGD) for use in the autumn/winter 2026/27 NHS Flu vaccination campaign. VGDs are a new legal route which can be used to authorise administration of vaccines. In summary, they operate in a similar [...] The post Flu and Childhood flu vac: PGD and VGD published appeared first on Community Pharmacy England.

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff experts have created a new video discussing prescription charges. In this video, we provide guidance on how pharmacy teams can determine the number of charges that apply to items dispensed against NHS prescriptions. In this video, Gemma Hackett (Dispensing and Supply [...] The post Funding & Reimbursement Shorts: Prescription charges – what does the patient pay? appeared first on Community Pharmacy England.

With the deadline now imminent, Community Pharmacy England is urging pharmacy owners to take action to finish and publish the Data Security and Protection Toolkit (DSPTK) for 2026 now and reminding them to make use of our resources to work through the process as efficiently as possible. Completion is already underway again this year – [...] The post Data Security Toolkit: Two weeks left to finish it appeared first on Community Pharmacy England.

Community pharmacy leaders, MPs and health stakeholders have gathered in Westminster to discuss the future of the sector and the part it can play in delivering care closer to home. LPC Chairs from across England met in Parliament on Monday 15th June, followed by a Parliamentary reception with MPs and other stakeholders about Neighbourhood Health. [...] The post LPC Chairs meet in Parliament to discuss pharmacy funding, reform and future strategy appeared first on Community Pharmacy England.

The UK Health Security Agency (UKHSA) and NHS England have published a letter providing further information on the Meningococcal (MenB) time limited vaccination offer. The letter follows on from the announcement last week, where the Department of Health and Social Care and NHS England announced a new community pharmacy vaccination service to provide a one-off [...] The post MenB: UKHSA and NHS England provide further information on vac service appeared first on Community Pharmacy England.

The product information for all ACE inhibitors is being updated to strengthen the warnings on the risk of delayed-onset angioedema, which may still occur after weeks to years of use. Healthcare professionals, particularly in emergency departments, should be aware of the potential for delayed onset of angioedema and the distinction between bradykinin- and histamine-mediated cases, [...] The post MHRA Drug Safety Update: ACE-inhibitors appeared first on Community Pharmacy England.

Community pharmacy is at the heart of the 10-Year Plan for the NHS, with this year’s investment into the CPCF a clear signal of Government’s commitment to the sector, Minister of State for Care Stephen Kinnock MP has told LPCs. Addressing the Forum of LPC Chairs in Westminster on Monday, Minister Kinnock described community pharmacy [...] The post Minister confirms commitment to pharmacy appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Cyclizine Lactate 50 mg/ml Solution for injection (Orbit Pharma Limited) Drug Alert Number: EL(26)A/29 Date issued: 16 June 2026 Orbit Pharma Limited is recalling a specific batch of Cyclizine Lactate 50 mg/ml Solution for injection as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies identified at the manufacturing site. [...] The post MHRA Class 3 Medicines Recall: Cyclizine Lactate 50 mg/ml Solution for injection (Orbit Pharma Limited) appeared first on Community Pharmacy England.

The General Pharmaceutical Council (GPhC) has published advice for newly qualified prescribing pharmacists, ahead of the first cohort joining the register as independent prescribers from summer 2026. The advice is aimed at pharmacists who have completed their MPharm under the 2021 initial education and training standards and will join the register as pharmacist independent prescribers. [...] The post Advice published for newly qualified prescribing pharmacists appeared first on Community Pharmacy England.